Search

everythinglearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Prescription and alternative therapies for hair loss will be compared for effectiveness.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Finasteride may help improve certain brain function issues linked to dopamine.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

A woman's severe insulin resistance improved with treatment, but she still had high testosterone levels due to ovarian issues.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

GFRα2 is essential for controlling neuron size but not for target innervation in certain sensory neurons.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Acanthosis nigricans is common in obese individuals, but not significantly linked to obesity type.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Ginsenoside Rb1 may help remodel hypertrophic scars effectively at a dose of 0.56 mg.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Ganoderma lucidum extract promotes hair growth in bald rats, with higher doses producing better results, similar to the effects of Minoxidil 2%.

Ginsenoside Rb1 slows down aging in mice by affecting cell growth, cell death, and metabolism.

Idiopathic hirsutism may be linked to increased enzyme activity.

Men with isolated hypogonadotropic hypogonadism have partial steroid deficiencies, while those with panhypopituitarism have severe deficiencies.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Normal androgen levels need ACTH, and different mechanisms control adrenarche and gonadarche.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.